Implementation of the Caregivers-Patients Support Coping with Advanced-Cancer (CASA) Intervention.

Launched by PONCE MEDICAL SCHOOL FOUNDATION, INC. · Mar 12, 2025

Keywords

ClinConnect Summary

The CASA trial is a research study aimed at helping patients with advanced cancer and their caregivers cope better with the challenges they face. This study focuses on developing a program called the Caregivers-Patients Support Coping with Advanced Cancer (CASA), which involves a series of five online sessions lasting about an hour each. The goal is to provide emotional and practical support to both patients and their caregivers, especially in communities where cancer care is not as effective. By testing this program, the researchers hope to improve the quality of care and support available for those affected by advanced cancer.

To participate in this study, patients need to be diagnosed with stage III or IV solid tumors and report feeling a significant level of distress. Caregivers identified by these patients are also eligible to join. However, individuals with major medical or mental health issues that could hinder their participation will not be included. Participants can expect to engage in supportive discussions and receive valuable resources tailored to their needs during the online sessions. This study is still in the planning phase and is not yet recruiting participants, but it aims to make a meaningful difference in the lives of patients and caregivers dealing with advanced cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Cancer patients must be stage III and IV solid tumor patients who report distress \>4 on the Distress Thermometer
• • Caregivers. Identified caregivers by distressed patients.
• Exclusion Criteria:
• • (1) diagnosed with a major disabling medical or psychiatric condition, (2) unable to understand the consent procedure, or (3) too ill to participate, all as reported by the participant and/or determined by the investigator's judgment.